231 related articles for article (PubMed ID: 25576994)
1. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology.
Yeh S; Kim SJ; Ho AC; Schoenberger SD; Bakri SJ; Ehlers JP; Thorne JE
Ophthalmology; 2015 Apr; 122(4):769-78. PubMed ID: 25576994
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis.
Régnier S; Malcolm W; Allen F; Wright J; Bezlyak V
PLoS One; 2014; 9(7):e102309. PubMed ID: 25029255
[TBL] [Abstract][Full Text] [Related]
3. Update on the Use of Anti-VEGF Intravitreal Therapies for Retinal Vein Occlusions.
Jiang Y; Mieler WF
Asia Pac J Ophthalmol (Phila); 2017; 6(6):546-553. PubMed ID: 29204993
[TBL] [Abstract][Full Text] [Related]
4. Laser and Anti-Vascular Endothelial Growth Factor Agent Treatments for Retinal Arterial Macroaneurysm.
Chen YY; Lin LY; Chang PY; Chen FT; Mai ELC; Wang JK
Asia Pac J Ophthalmol (Phila); 2017; 6(5):444-449. PubMed ID: 28828763
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology.
Smith JR; Thorne JE; Flaxel CJ; Jain N; Kim SJ; Maguire MG; Patel S; Weng CY; Yeh S; Kim LA
Ophthalmology; 2024 Apr; ():. PubMed ID: 38647511
[TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future.
Kwong TQ; Mohamed M
Br J Clin Pharmacol; 2014 Oct; 78(4):699-706. PubMed ID: 24602183
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of antivascular endothelial growth factors for central retinal vein occlusion: A protocol for systematic review and network meta-analysis.
Liu Z; Wang S; Ma A; Zhao B
Medicine (Baltimore); 2021 Dec; 100(52):e28283. PubMed ID: 34967360
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal ranibizumab injection is associated with an increased risk of chronic kidney disease: a population-based study in Taiwan.
Chen CH; Lim PS; Wu TK; Chuang WL; Yu TS; Tsai FJ; Chen CM; Chang KH
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4799-4808. PubMed ID: 38153512
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and current treatment of age-related macular degeneration.
Yonekawa Y; Kim IK
Cold Spring Harb Perspect Med; 2014 Oct; 5(1):a017178. PubMed ID: 25280900
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature.
Polizzi S; Mahajan VB
J Ocul Pharmacol Ther; 2015 Dec; 31(10):605-10. PubMed ID: 26302032
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of clinical practice guidelines for the diagnosis and management of retinal vein occlusion.
Galvez-Olortegui J; Bouchikh-El Jarroudi R; Silva-Ocas I; Palacios-Herrera H; Cubillas-Martin M; Zavaleta-Mercado M; Burgueño-Montañes C; Galvez-Olortegui T
Eye (Lond); 2024 Jun; 38(9):1722-1733. PubMed ID: 38467863
[TBL] [Abstract][Full Text] [Related]
12. Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases.
Lanzetta P; Loewenstein A;
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1259-1273. PubMed ID: 28527040
[TBL] [Abstract][Full Text] [Related]
13. Retinal Vein Occlusion Review.
Ip M; Hendrick A
Asia Pac J Ophthalmol (Phila); 2018; 7(1):40-45. PubMed ID: 29280368
[TBL] [Abstract][Full Text] [Related]
14. The role of intravitreal anti-vascular endothelial growth factor injection in peripheral exudative hemorrhagic chorioretinopathy: A systematic review.
Gowda A; Bahrami B; Jie WWJ; Casson R; Chan WO
Surv Ophthalmol; 2024; 69(2):173-178. PubMed ID: 37806565
[TBL] [Abstract][Full Text] [Related]
15. Update on Retinal Vein Occlusion.
Romano F; Lamanna F; Gabrielle PH; Teo KYC; Battaglia Parodi M; Iacono P; Fraser-Bell S; Cornish EE; Nassisi M; Viola F; Agarwal A; Samanta A; Chhablani J; Staurenghi G; Invernizzi A
Asia Pac J Ophthalmol (Phila); 2023 Mar-Apr 01; 12(2):196-210. PubMed ID: 36912792
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.
Nikkhah H; Karimi S; Ahmadieh H; Azarmina M; Abrishami M; Ahoor H; Alizadeh Y; Behboudi H; Daftarian N; Dehghan MH; Entezari M; Farrahi F; Ghanbari H; Falavarjani KG; Javadi MA; Karkhaneh R; Moradian S; Manaviat MR; Mehryar M; Nourinia R; Parvaresh MM; Ramezani A; Haghi AR; Riazi-Esfahani M; Soheilian M; Shahsavari M; Shahriari HA; Rajavi Z; Safi S; Shirvani A; Rahmani S; Sabbaghi H; Pakbin M; Kheiri B; Ziaei H
J Ophthalmic Vis Res; 2018; 13(2):158-169. PubMed ID: 29719645
[TBL] [Abstract][Full Text] [Related]
17. Local delivery of corticosteroids in clinical ophthalmology: A review.
Fung AT; Tran T; Lim LL; Samarawickrama C; Arnold J; Gillies M; Catt C; Mitchell L; Symons A; Buttery R; Cottee L; Tumuluri K; Beaumont P
Clin Exp Ophthalmol; 2020 Apr; 48(3):366-401. PubMed ID: 31860766
[TBL] [Abstract][Full Text] [Related]
18. Recent Innovations in Medical and Surgical Retina.
Bhagat N; Zarbin M
Asia Pac J Ophthalmol (Phila); 2013; 2(4):244-52. PubMed ID: 26106919
[TBL] [Abstract][Full Text] [Related]
19. Current Best Clinical Practices-Management of Retinal Vein Occlusion.
Modi YS; Klufas MA; Sridhar J; Singh RP; Yonekawa Y; Pecen P
J Vitreoretin Dis; 2020 Jun; 4(3):214-219. PubMed ID: 37007445
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of macular edema.
Haydinger CD; Ferreira LB; Williams KA; Smith JR
Front Med (Lausanne); 2023; 10():1128811. PubMed ID: 36960343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
